Investors / Netherlands / ALS Investment Fund
ALS Investment Fund
Venture capital · Amsterdam, Netherlands · Europe
ALS Investment Fund is a venture capital fund that invests in biotech companies developing drugs for neurodegeneration, with a particular focus on ALS. It is managed by SUNU Ventures in Amsterdam, The Netherlands.
Invests inHealthcare & Biotech
In its own wordsbiotechneurodegenerationalsdrug developmenttherapeutics
Your fit with ALS Investment Fund
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsALS Investment Fund lists 7 checked portfolio companies on its own site and is named in 1 funding round. Its largest themes are Healthcare & Biotech (86%) and AI & Machine Learning (14%). 60% of its companies are based in United States. It invests most often alongside OS Fund, +ND Capital and ATEL Ventures.
Counts come from funding rounds that name ALS Investment Fund, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundALS Investment Fund does not state its stages on its site, so only what it does is shown.
The rounds that name ALS Investment Fund do not give a stage.
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 12th | 7 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 94th | 86% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| OS Fund | 2 |
| +ND Capital | 1 |
| ATEL Ventures | 1 |
| Agent Capital | 1 |
| Alwyn Capital | 1 |
| Apollo Health Ventures | 1 |
| Beyond Impact | 1 |
| CSC Upshot | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers686%
- No longer answers00%
- Points to another company114%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 86% | 15% |
| AI & Machine Learning | 14% | 18% |
Co-investor network
who it backs companies with, and who they back togetherCompare ALS Investment Fund head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
7 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Bloom Science is a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Emulate makes Organ-Chips for research and development | Healthcare & Biotech | Portfolio page | ||
| The company engages in activities and investments related to biopharmaceutical research and development | Healthcare & Biotech | Portfolio page | ||
| Prilenia is dedicated to developing new treatments for neurodegenerative diseases such as Huntington's disease and amyotrophic lateral sclerosis (ALS). | Healthcare & Biotech | Portfolio page | ||
| QurAlis discovers and develops effective precision medicines for neurodegenerative and neurological diseases | Healthcare & Biotech | Portfolio page | ||
Healthcare & BiotechAI & Machine Learning | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- alsinvestmentfund.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 11 Nov 2026
- Companies checked
- 7
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get ALS Investment Fund's profile as data
Pull ALS Investment Fund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/alsinvestmentfund.com
# also
GET /v1/firms/alsinvestmentfund.com/portfolio
GET /v1/firms/alsinvestmentfund.com/coinvestors
GET /v1/firms/alsinvestmentfund.com/news